Headline
The latest stories from AHA Today.
The Departments of Health and Human Services, Treasury and Labor released its transparency-in-coverage final rule imposing new requirements upon group health plans and issuers of health insurance coverage in the individual and group markets.
“The COVID-19 pandemic has proved that crisis tends to be a driver of innovation,” writes Jonathan Bandel, vice president of strategy and innovation for New York’s White Plains Hospital.
The Food and Drug Administration updated its guidance on enforcement policy for non-invasive remote monitoring devices that support patient monitoring during the COVID-19 public health emergency.
Over 10,000 eligible nursing homes, or 76% of the field, will receive a portion of $333 million in COVID-19 Provider Relief Funds for meeting infection control and mortality criteria in effect from August through September.
The departments of Health and Human Services and Defense have agreed to purchase the first 300,000 doses of the investigational antibody drug bamlanivimab, also known as LY-CoV555, which state and territorial health departments will distribute to health care facilities for use in COVID-19…
The Centers for Medicare & Medicaid Services announced an interim final rule establishing additional Medicare hospital payment to support Medicare beneficiaries’ access to COVID-19 vaccines and new treatments when they become available.
In an interim final rule, the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology extended to April 5, 2021, the deadline to comply with the information blocking requirements in its final rule. The original deadline was Nov. 2, 2020.
Essa Mohamed, a National Institutes of Health Fellow at Mayo Clinic’s Department of Cardiovascular Medicine, speaks with Elisa Arespacochaga, vice president of AHA’s Physician Alliance, about strategies to increase the number of women and underrepresented minorities in clinical research to advance…
Adults should be screened for colon cancer beginning at age 45 rather than 50, even in the absence of symptoms and personal or family history related to colorectal cancer, the U.S. Preventive Services Task Force said in a draft recommendation statement.
Ninety-eight percent of eligible clinicians who reported data in the 2019 Quality Payment Program through the Merit-based Incentive Payment System track will receive a positive payment adjustment in 2021, with 84% receiving an additional adjustment for exceptional performance, the Centers for…